Huw M. Nash Stoke Therapeutics, Inc. (STOK) insider trading activity

Huw M. Nash is Chief Business Officer of Stoke Therapeutics, Inc.. Currently has a direct ownership of 0 shares of STOK, which is worth approximately $0. The most recent transaction as insider was on Jul 02, 2024, when has been sold 2,500 shares (Common Stock) at a price of $13.5 per share, resulting in proceeds of $33,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Huw M. Nash Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 02 2024	SELL Open market or private sale	$33,750 $13.5 p/Share	2,500 Reduced 100.0%	0 Common Stock
May 20 2024	SELL Open market or private sale	$769,500 $15.39 p/Share	50,000 Reduced 100.0%	0 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	$20,000 $0.4 p/Share	50,000 Added 50.0%	50,000 Common Stock
Apr 01 2024	SELL Open market or private sale	$823,035 $13.42 p/Share	61,329 Reduced 100.0%	0 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$20,000 $0.4 p/Share	50,000 Added 44.91%	61,329 Common Stock
Mar 19 2024	SELL Open market or private sale	$25,107 $6.1 p/Share	4,116 Reduced 26.65%	11,329 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	13,100 Added 45.89%	15,445 Common Stock
Jan 03 2022	SELL Open market or private sale	$88,578 $23.31 p/Share	3,800 Reduced 100.0%	0 Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$8,322 $2.19 p/Share	3,800 Added 50.0%	3,800 Common Stock
Dec 01 2021	SELL Open market or private sale	$139,707 $24.51 p/Share	5,700 Reduced 100.0%	0 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 50.0%	5,700 Common Stock
Nov 03 2021	SELL Open market or private sale	$47,500 $25.0 p/Share	1,900 Reduced 100.0%	0 Common Stock
Nov 03 2021	BUY Exercise of conversion of derivative security	$4,161 $2.19 p/Share	1,900 Added 50.0%	1,900 Common Stock
Nov 01 2021	SELL Open market or private sale	$89,566 $23.57 p/Share	3,800 Reduced 100.0%	0 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$8,322 $2.19 p/Share	3,800 Added 50.0%	3,800 Common Stock
Oct 01 2021	SELL Open market or private sale	$141,531 $24.83 p/Share	5,700 Reduced 100.0%	0 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 50.0%	5,700 Common Stock
Sep 01 2021	SELL Open market or private sale	$148,200 $26.0 p/Share	5,700 Reduced 100.0%	0 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 50.0%	5,700 Common Stock
Aug 02 2021	SELL Open market or private sale	$164,559 $28.87 p/Share	5,700 Reduced 100.0%	0 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 50.0%	5,700 Common Stock
Jul 01 2021	SELL Open market or private sale	$189,981 $33.33 p/Share	5,700 Reduced 100.0%	0 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$12,483 $2.19 p/Share	5,700 Added 50.0%	5,700 Common Stock
Jun 01 2021	SELL Open market or private sale	$22,672 $39.43 p/Share	575 Reduced 100.0%	0 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$1,259 $2.19 p/Share	575 Added 50.0%	575 Common Stock

HMN

Huw M. Nash

Chief Business Officer

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Value

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Stoke Therapeutics, Inc.

Track Activities on STOK

Account